Back to search
GIST, Malignant
Clinical trial pipeline · Data from ClinicalTrials.gov
See which GIST, Malignant trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which GIST, Malignant trials you may qualify forObjective: To follow people with GISTs and collect tumor tissue so that it can be studied in the lab. Eligibility: People age 6 and older who have a GIST. D…
In this clinical trial, the safety, tolerability, and preliminary antitumor activity of ziftomenib in combination with imatinib will be evaluated in adults with…
The purpose of the study is to investigate whether a personalized selection of patients with localized soft tissue sarcoma for preoperative proton radiation the…
The purpose of this study is to develop and test a new communication training intervention called Hematolo-GIST to help oncologists communicate with patients ab…
The PARTNER study is an international, prospective, observational study of paediatric patients with very rare tumours.
This is a prospective, multicenter, observational real-world study to explore the therapy patterns and clinical outcomes of Avapritinib in patients with metasta…
This phase II trial studies nivolumab and ipilimumab in treating patients with rare tumors. Immunotherapy with monoclonal antibodies, such as nivolumab and ipil…
This phase II MATCH treatment trial tests how well sunitinib in treating patients with cancer that has certain genetic changes. Sunitinib is in a class of medic…